Skip to main content
Premium Trial:

Request an Annual Quote

ExonHit, Genmab Reach Agreement on Breast Cancer Splice Variants

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ExonHit and Genmab today announced an agreement for the selection of novel splice variants that may have potential as therapeutic targets for breast cancer.

Under the terms of the agreement, Genmab retains exclusive development and commercialization rights to 10 events from a breast cancer database developed using ExonHit's genome-wide SpliceArray technology, ExonHit said in a statement. The 10 are sequences indicative of alternative splicing events in targets "suitable for developing antibody-based therapeutics," the company said. Genmab retains those sequences for further characterization.

Genmab also has first negotiation rights on epitopes that may be characterized by ExonHit from the data resulting from its work on the 10 sequences. ExonHit keeps full rights on all uses of the breast cancer database, which includes more than 2,700 RNA sequences that are expressed specifically in breast cancer tissue. About 400 sequences may lead to new epitopes for antibody discovery in the treatment of breast cancer, the company said.

The splice variants covered by the agreement were part of a pilot study that demonstrated the ability of the SpliceArray platform to identify novel target candidates for breast cancer treatment, ExonHit said.

Financial terms of the deal were not disclosed.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.